Covestro (ETR:1COV) Given a €120.00 Price Target by Kepler Capital Markets Analysts

Share on StockTwits

Kepler Capital Markets set a €120.00 ($139.53) target price on Covestro (ETR:1COV) in a research note issued to investors on Wednesday, October 10th. The brokerage currently has a buy rating on the stock.

A number of other equities analysts have also issued reports on the stock. Barclays set a €98.00 ($113.95) target price on shares of Covestro and gave the stock a neutral rating in a research report on Friday, June 29th. UBS Group set a €100.00 ($116.28) target price on shares of Covestro and gave the stock a buy rating in a research report on Wednesday, October 10th. JPMorgan Chase & Co. set a €105.00 ($122.09) price target on shares of Covestro and gave the stock a buy rating in a research note on Tuesday, June 26th. Baader Bank set a €84.00 ($97.67) price objective on Covestro and gave the stock a buy rating in a report on Tuesday, June 26th. Finally, Commerzbank set a €110.00 ($127.91) price objective on Covestro and gave the stock a buy rating in a report on Friday, July 27th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have given a buy rating to the stock. Covestro has an average rating of Hold and a consensus target price of €90.67 ($105.43).

Shares of 1COV opened at €57.56 ($66.93) on Wednesday. Covestro has a one year low of €61.95 ($72.03) and a one year high of €96.32 ($112.00).

Covestro Company Profile

Covestro AG develops, produces, and markets polymer materials for various industries worldwide. The company operates in three segments: Polyurethanes; Polycarbonates; and Coatings, Adhesives, Specialties. The Polyurethanes segment offers precursors, such as flexible polyurethane foam primarily used in the furniture and automotive industries; and rigid foam used as insulating material in the construction industry and in refrigeration chains.

Featured Article: Price to Earnings Ratio (PE), For Valuing Stocks

Analyst Recommendations for Covestro (ETR:1COV)

Receive News & Ratings for Covestro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covestro and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.